Stocksigma LogoStocksigma Logo

NPPA Issues Demand Notice to Akums Drugs Subsidiary and Hetero Healthcare

Akums Drugs and Pharmaceuticals' wholly-owned subsidiary, Pure and Cure Healthcare, alongside marketer Hetero Healthcare and Abaris Healthcare, received an

NPPA Issues Demand Notice to Akums Drugs Subsidiary and Hetero Healthcare

Akums Drugs and Pharmaceuticals Ltd 路 Others (Uncategorized) 路 15 Oct 2026, 10:08 pm

NPPA Issues Demand Notice to Akums Drugs Subsidiary and Hetero Healthcare Akums Drugs and Pharmaceuticals' wholly-owned subsidiary, Pure and Cure Healthcare, alongside marketer Hetero Healthcare and Abaris Healthcare, received an NPPA demand notice dated 13th Oct'26 for Rs 52.75 cr. The demand relates to alleged DPCO 2013 pricing violations for formulation "Lanol 1000 mg injection" manufactured between Dec'17 and Aug'24, comprising Rs 18.95 cr overcharging, Rs 18.95 cr penalty, and Rs 14.85 cr interest. Akums clarified that primary response liability lies with marketer Hetero Healthcare under contractual indemnity clauses holding marketers solely liable for DPCO breaches.

Original exchange filing (PDF)

More announcements from Akums Drugs and Pharmaceuticals Ltd

All Akums Drugs and Pharmaceuticals Ltd announcements